Australian Clinical Labs Ltd Cash Flow-to-Debt Ratio
Australian Clinical Labs Ltd cash flow-to-debt ratio. Australian Clinical Labs Ltd (ACL) has a Cash Flow-to-Debt Ratio of 0.15x as of December 2025, meaning its operating cash flow of AU$62.87 Million could theoretically repay 0% of its total liabilities (AU$411.46 Million) in one year. Check Australian Clinical Labs Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Australian Clinical Labs Ltd (2016–2025)
Cash flow-to-debt ratio of Australian Clinical Labs Ltd from 2016 to 2025. Historical debt coverage capacity for Australian Clinical Labs Ltd across 18 annual periods. Check Australian Clinical Labs Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Australian Clinical Labs Ltd Cash Flow-to-Debt Ratio by Year (2016–2025)
Australian Clinical Labs Ltd cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for Australian Clinical Labs Ltd. For the full cash flow conversion analysis, see Australian Clinical Labs Ltd cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | AU$182.80 Million | AU$402.86 Million | ▲ +0.0% |
| 2024 | 0.45x | AU$182.80 Million | AU$402.86 Million | ▲ +18.1% |
| 2024 | 0.38x | AU$159.59 Million | AU$415.30 Million | ▲ +0.0% |
| 2023 | 0.38x | AU$159.59 Million | AU$415.30 Million | ▲ +8.7% |
| 2023 | 0.35x | AU$143.68 Million | AU$406.24 Million | ▲ +0.0% |
| 2022 | 0.35x | AU$143.68 Million | AU$406.24 Million | ▼ -50.8% |
| 2022 | 0.72x | AU$284.09 Million | AU$395.49 Million | ▲ +0.0% |
| 2021 | 0.72x | AU$284.09 Million | AU$395.49 Million | ▲ +83.4% |
| 2021 | 0.39x | AU$153.86 Million | AU$392.79 Million | ▲ +0.0% |
| 2020 | 0.39x | AU$153.86 Million | AU$392.79 Million | ▲ +14.4% |
| 2020 | 0.34x | AU$101.74 Million | AU$297.06 Million | ▲ +0.0% |
| 2019 | 0.34x | AU$101.74 Million | AU$297.06 Million | ▲ +3786.4% |
| 2019 | 0.01x | AU$1.11 Million | AU$126.19 Million | ▲ +0.0% |
| 2018 | 0.01x | AU$1.11 Million | AU$126.19 Million | ▼ -78.7% |
| 2018 | 0.04x | AU$4.69 Million | AU$113.60 Million | ▲ +0.0% |
| 2017 | 0.04x | AU$4.69 Million | AU$113.60 Million | ▼ -4.2% |
| 2017 | 0.04x | AU$4.60 Million | AU$106.77 Million | ▲ +0.0% |
| 2016 | 0.04x | AU$4.60 Million | AU$106.77 Million | — |